|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/52 | |
| A61K 35/12 | |||
| A61K 39/395 | |||
| A61K 45/00 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Number of the document | 3122360 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15768602.3 |
| Date of filing the European patent application | 2015-03-24 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/001676 |
| Date | 2015-03-24 |
| (87) | Number | WO 2015/146159 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| 2014061413 | 2014-03-25 | JP |
| (72) |
YOSHIZAWA, Toshio, JP
KOZAKI, Ryohei, JP
|
| (73) |
ONO Pharmaceutical Co., Ltd.,
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526,
JP
|
| (54) | PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR DIFFUSE LARGE B-CELL LYMPHOMA |
| PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR DIFFUSE LARGE B-CELL LYMPHOMA |